zinc finger protein 37C, pseudogeneGenealiases: BA775A3.1 · ZNF37C
Q-omics provides the consensus-scored ZNF37CP profile across patient tissues and cancer cell-line models. ZNF37CP expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, ZNF37CP is differentially expressed in 12, with the highest sampling consensus in KIRC. Additionally, ZNF37CP RNA expression shows 12,968 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight KICH, KIRC, and UVM as cancer lineages where ZNF37CP shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ZNF37CP — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ZNF37CP survival associations across molecular data types. ZNF37CP RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ZNF37CP RNA expression–survival associations across cancer types. High ZNF37CP expression shows unfavorable associations in KICH, DLBC, KIRP and LIHC, but favorable associations in KIRC and STAD. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for ZNF37CP RNA expression.
This table summarizes ZNF37CP tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for ZNF37CP. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ZNF37CP shows lower tumor expression in THCA, BRCA and READ and higher tumor expression in KIRC, HNSC and KIRP. The KIRC box plot shows higher ZNF37CP RNA expression in tumor versus normal tissue (log2 FC = +2.466, t-test p < 0.001).
This table shows molecular features associated with ZNF37CP in patient tissues and cancer cell lines. In patient samples, ZNF37CP shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
